ITUS Corp. | Mutual Funds
Mutual Funds that own ITUS Corp.
Vanguard Total Stock Market Index Fund
347,601
1.86%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
196,184
1.05%
200
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
62,373
0.33%
0
0%
07/31/2018
iShares Micro Cap ETF
37,921
0.2%
0
0.01%
09/06/2018
Fidelity Spartan Total Market Index Fund
25,229
0.14%
0
0%
07/31/2018
Vanguard Institutional Total Stock Market Index Fund
16,448
0.09%
0
0%
07/31/2018
Vanguard Balanced Index Fund
12,776
0.07%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
4,820
0.03%
0
0%
09/06/2018
4,740
0.03%
0
0.06%
09/05/2018
Hera SICAV
4,400
0.02%
0
0.05%
06/30/2017
| Address |
3150 Almaden Expressway
San Jose California 95118
United States
|
|
Employees
|
- |
| Website |
http://www.ituscorp.com |
| Updated |
09/14/2018 |
| ITUS Corp. engages in the development, acquisition and licensing emerging technology in the field of biotechnology. It focuses on platform called Cchek, a series of inexpensive non-invasive blood tests for the early detection of cancer, which is based on the body's immunological response to the presence of a malignancy. The company was founded on November 5, 1982 and is headquartered San Jose, CA. |
